VT News
Lawrence Okoye

Lawrence Okoye

Ask VT AI
View News Summary
  • Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Ask VT AI
View News Summary
  • Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Lawrence Okoye

Top Topics

Trending in U.S.

World

Sport